< Back to Article
Anti-HDV IgM as a Marker of Disease Activity in Hepatitis Delta
Figure 5
Histological staging of the HIDIT-2 cohort.
Diagrammed% of patients with cirrhosis (based on the classification indicated in material and methods) within the anti-HDV IgM groups.
doi: https://doi.org/10.1371/journal.pone.0101002.g005